Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01627 |
| Species: | Homo sapiens |
| Position : | chr17:31255800-31256300 |
| Year: | 2021 |
| Title: | TNF-??-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | pancreatic ductal adenocarcinoma |
| PMID: | 35122059 |
| MONDO: | MONDO:0005147 |
| Tissue: | Pancreas |
| Tissue Ontology ID: | UBERON:0001264 |
| Cell Source: | AsPC-1 |
| CVCL ID: | CVCL_0152 |
| Cell Type: | pancreatic ductal adenocarcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | TF binding assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, ATAC-seq, RNA-seq |
| Low Throughput Method: | ChIP-RT-qPCR, siRNA Knockdown, RT-RT-qPCR, Western blot, ELISA |
| Target gene : | CCL2 |
| TF name : | CJUN |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|